Last updated: October 25, 2026

Application No. 18/285,918

PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS

Non-Final OA

Filed

Oct 06, 2023

Priority

Apr 09, 2021 — provisional 63/173,055 +1 more

Examiner

TRUONG, QUANGLONG N

Art Unit

1615

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Avantor Performance Materials, LLC

OA Round

2 (Non-Final)

Interview Optional

— +23.3% interview lift. Examiner has a relatively high allowance rate (79%); +23.3% interview lift. A written response may suffice.

Based on 659 resolved cases, 2023–2026

Examiner Intelligence

TRUONG, QUANGLONG N View full profile →

Grants 79% — above average

Career Allowance Rate

518 granted / 659 resolved

+18.6% vs TC avg

Strong +23% interview lift

Without

With

+23.3%

Interview Lift

resolved cases with interview

Typical timeline

2y 3m

Avg Prosecution

53 currently pending

Career history

717

Total Applications

across all art units

Statute-Specific Performance

§101

4.2%

-35.8% vs TC avg

§103

55.1%

+15.1% vs TC avg

§102

11.1%

-28.9% vs TC avg

§112

18.4%

-21.6% vs TC avg

Black line = Tech Center average estimate • Based on career data from 659 resolved cases

Prosecution Timeline

Oct 06, 2023

Application Filed

Oct 31, 2025

Non-Final Rejection mailed

Apr 30, 2026

Response Filed

Jul 27, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/977,195

Patent 12765545

PREPARATION OF A DRY BIOMASS EXTRACT RICH IN POLYPHENOLS

3y 11m to grant Granted Oct 20, 2026

18/696,281

Patent 12765557

CERIUM OXIDE NANOPARTICLE, DISPERSION SOLUTION, ANTIVIRAL AGENT, ANTIBACTERIAL AGENT, RESIN COMPOSITION, RESIN PRODUCT, FIBER MATERIAL, FIBER PRODUCT, AND METHOD OF PRODUCING CERIUM OXIDE NANOPARTICLE

2y 6m to grant Granted Oct 20, 2026

18/445,907

Patent 12758472

Formulation for treatment of melasma, hyperpigmentation, and dark spots

2y 6m to grant Granted Oct 13, 2026

17/796,451

Patent 12751968

IMPROVEMENT IN PULMONARY ARTERIAL COMPLIANCE WITH INHALED NITRIC OXIDE (iNO) TREATMENT

4y 2m to grant Granted Oct 06, 2026

18/011,706

Patent 12751989

WATER SOLUBLE CURCUMINOIDS COMPOSITION FOR TREATING MOUTH AND THROAT CONDITIONS

3y 9m to grant Granted Oct 06, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

79%

Grant Probability

99%

With Interview (+23.3%)

2y 3m (~0m remaining)

Median Time to Grant

Moderate

PTA Risk

Based on 659 resolved cases by this examiner. Grant probability derived from career allowance rate.